Restrictions on Public Procurement from certain countries

The Government of India today amended the General Financial Rules 2017 to enable imposition of restrictions on bidders from countries which share a land border with Indiaon grounds of defence of India, or matters directly or indirectly related thereto including national security.

Go to Source
Author:




Agricultural products need to be marketed in domestic and international markets in such a way as to reduce cost of production : Sh. Nitin Gadkari

Union Minister for Micro, Small and Medium Enterprises Nitin Gadkari today opined  that,  the products produced by the Farmer Producer Company (FPC)  need to be marketed in the domestic and international markets in  such a manner that would reduce the cost of production.

Go to Source
Author:




New Specified Health Warning on Tobacco Products packs

The Ministry of Health and Family Welfare, Government of India has notified new sets of specified health warnings for all tobacco product packs by making an amendment in the Cigarettes and other Tobacco Products (Packaging and Labelling) Rules, 2008 vide GSR 458 (E) dated 21st July, 2020 “The Cigarettes and other Tobacco Products (Packaging and Labelling) Third Amendment Rules, 2020”.

Go to Source
Author:




Shri Piyush Goyal calls for all nations to enhance transparency in their trade and build trust;

The Commerce and Industry Minister Shri Piyush Goyal has called for all nations to enhance transparency in their trade and build trust to prevent losing their role as a preeminent trade partner. Addressing the 10th BRICS Trade Ministers virtual Meeting today, he said that for trade to play its part in the recovery process, all the partners must be trustworthy and transparent.

Go to Source
Author:




Cost Effective Process Technology of Favipiravir Developed by CSIR Used by M/s Cipla Ltd., for Scale up & the Repurposed Drug Expected to be Launched Soon

An off patent anti-viral drug Favipiravir, originally discovered by Fuji, Japan has shown promise in clinical trials for treatment of Covid-19 patients, especially the mild and the moderate patients.

 

CSIR constituent lab CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has developed a cost effective process using locally available chemicalsto synthesize this Active Pharmaceutical Ingredient (API) and transferred the technology to leading pharmaceutical industry M/s Cipla Limited.

Go to Source
Author: